Understanding how the immune system detects and responds to viral infections.
Defining the differential roles of HOIL1 and the Linear Ubiquitin Chain Assembly Complex in interferon induction by MDA5 and RIG-I during viral infection.
This study is looking at how certain proteins help your body fight off viruses by producing important substances called interferons, and it aims to find new ways to improve treatments and vaccines for viral infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11089316 on NIH RePORTER |
What this research studies
This research investigates the roles of specific proteins in the immune response to viral infections, focusing on how the body produces interferons, which are crucial for fighting viruses. The study examines two key sensors, RIG-I and MDA5, that detect viral RNA and trigger the immune response. By exploring the mechanisms that regulate interferon production, the research aims to identify new strategies for preventing and treating viral infections. Patients may benefit from insights that could lead to improved therapies or vaccines against viral diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with autoimmune conditions or those affected by viral infections.
Not a fit: Patients with non-viral infections or those not affected by autoimmune diseases may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments or vaccines for viral infections, improving patient outcomes.
How similar studies have performed: Previous research has shown success in understanding immune responses to viral infections, indicating that this approach has potential for meaningful advancements.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Macduff, Donna a — University of Illinois at Chicago
- Study coordinator: Macduff, Donna a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.